Related Experiment Video

Updated: May 6, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

21.9K

Cyclophilin-A: a novel biomarker for untreated male essential hypertension

Chen-Shu Chang1, Shih-Li Su, Chia-Chu Chang

  • 1Department of Neurology, Changhua Christian Hospital , Changhua , Taiwan .

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|October 30, 2013
PubMed

Insights

Plasma cyclophilin-A (CyP-A) is a key biomarker in early essential hypertension. This study found elevated CyP-A levels in hypertensive individuals, correlating with blood pressure.

Area of Science:

  • Cardiovascular research
  • Biomarker discovery
  • Hypertension pathogenesis

Background:

  • Vascular cytokines, nitrite, and cyclophilin-A (CyP-A) are implicated in hypertension.
  • Essential hypertension affects a significant portion of the population.
  • Early identification of pathogenesis markers is crucial.

Purpose of the Study:

  • To investigate the role of vascular cytokines, total nitrite, and plasma CyP-A in untreated essential hypertension.
  • To identify significant molecular contributors to hypertension.
  • To establish plasma CyP-A as a potential early biomarker.

Main Methods:

  • Recruitment of 40 males with normotensive and untreated essential hypertension.
  • Measurement of vascular cytokines, total nitrite, and plasma CyP-A.
  • Analysis of Body Mass Index (BMI) and hyperlipidemia.
  • Multiple regression analysis to determine significant contributors.
  • Correlation analysis with systolic and diastolic blood pressure.

Main Results:

  • Hypertensive group showed increased BMI, hyperlipidemia, and plasma CyP-A.
  • Multiple regression identified BMI and plasma CyP-A as significant contributors to hypertension.
  • Plasma CyP-A positively correlated with both systolic and diastolic blood pressure.

Conclusions:

  • Plasma CyP-A is a critical molecular biomarker in the early pathogenesis of essential hypertension.
  • Elevated plasma CyP-A levels are associated with hypertension.
  • CyP-A may serve as an early indicator for hypertension risk.

More Related Videos

Intracellular Staining and Flow Cytometry to Identify Lymphocyte Subsets within Murine Aorta, Kidney and Lymph Nodes in a Model of Hypertension09:20

Intracellular Staining and Flow Cytometry to Identify Lymphocyte Subsets within Murine Aorta, Kidney and Lymph Nodes in a Model of Hypertension

Published on: January 28, 2017

17.5K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K